Last reviewed · How we verify

NCT03911609

Cardiovascular Autonomic Function and Endogenous Pain Modulation

Status unknown NA Last updated 11 April 2019
What this trial tests

NA trial testing Exercise in Fibromyalgia in 250 participants. Status unknown.

Timeline
20 March 2019
Primary endpoint
30 December 2022
30 December 2022

Quick facts

Lead sponsorMarquette University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment250
Start date20 March 2019
Primary completion30 December 2022
Estimated completion30 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Marquette University

Who can join

Adults 18 to 75, any sex, with Fibromyalgia or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study has three aims: 1. To investigate the influence of cardiovascular autonomic function on pain sensitivity at rest in patients with fibromyalgia and age- and sex-matched controls 2. To investigate the influence of cardiovascular autonomic function at baseline and during exercise on the pain response following submaximal isometric exercise 3. To study the relation between the pain response following physical and cognitive tasks (exercise and mental math, respectively).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Marquette University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03911609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing